Although cancer of the appendix is rare — typically, it's estimated to affect about 1 or 2 people for every 1 million in the ...

The firm will assess irpagratinib plus best supportive care in patients with FGF19-overexpressing advanced liver cancer.

The cure to cancer may not be hidden in some drug or chemical but within our own body. A team of Chinese researchers recently ...

Several cancers are becoming more common in young adults, including testicular cancer, melanoma, and cervical cancer. Blood-related cancers like B-cell lymphomas and plasma cell neoplasms are also on ...

We’ve all had those days when our stomachs feel a little off, maybe it’s a bit of bloating, or that all-too-familiar feeling ...

More people under 50 are getting appendix cancer. Here's what to know about this type of cancer, as well as why case rates ...

The U.S. FDA has approved treatment with Ibtrozi for patients with locally advanced or metastatic ROS1-positive non-small ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer ...

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

Gastric cancer, which is the fifth most frequent cancer globally and the third most frequent cause of cancer-related deaths, can be managed relatively well with existing therapies. Advanced gastric ...